Upgrade to SI Premium - Free Trial

KYNB (KYNB)

7.00 -0.13 (1.82%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Kyntra Bio presents roxadustat data showing transfusion improvements in MDS June 11, 2026 4:06 PM - StreetInsider Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes June 11, 2026 4:05 PM - Globe NewsWire Rodman & Renshaw Starts Kyntra Bio (KYNB) at Buy June 9, 2026 7:01 AM - StreetInsider Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026 4:05 PM - Globe NewsWire Kyntra Bio to Report First Quarter 2026 Financial Results May 4, 2026 4:05 PM - Globe NewsWire RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation April 10, 2026 12:56 PM - StreetInsider Kyntra Bio receives Nasdaq delisting notice for asset requirement April 9, 2026 4:14 PM - StreetInsider Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference April 8, 2026 4:05 PM - Globe NewsWire Full Article List